Evidence map›Paper›PMID 21875351›Full record

Trial reportJournal of alternative and complementary medicine (New York, N.Y.)2011

Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers.

Jason Allen, Ryan D Bradley

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of alternative and complementary medicine (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. A Short-Term Safety Evaluation of SilbinolJournal of evidence-based integrative medicine
    Trial
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jason AllenBastyr University Research Institute, Kenmore, WA, USA.
Ryan D Bradley
Bastyr University · USUniversity of Washington · US

Funding

Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
Complementary and Alternative Medicine Detoxification: Safety and EfficacyK99AT004711 · NCCIH · UNIVERSITY OF WASHINGTON · PI ALLEN, JASON · 2009 to 2010
$180k
NCCIH NIH HHS 1 K99 AT004711-01A1NCRR NIH HHS 1KL2RR025015-0
6 · The paper itself

Abstract

backgroundThe tripeptide glutathione (GSH) is the most abundant free radical scavenger synthesized endogenously in humans. Increasing mechanistic, clinical, and epidemiological evidence demonstrates that GSH status is significant in acute and chronic diseases. Despite ease of delivery, little controlled clinical research data exist evaluating the effects of oral GSH supplementation.

objectivesThe study objectives were to determine the effect of oral GSH supplementation on biomarkers of systemic oxidative stress in human volunteers.

designThis was a randomized, double-blind, placebo-controlled clinical trial. SETTING/LOCATION: The study was conducted at Bastyr University Research Institute, Kenmore, WA and the Bastyr Center for Natural Health, Seattle, WA. SUBJECTS: Forty (40) adult volunteers without acute or chronic disease participated in this study.

interventionOral GSH supplementation (500 mg twice daily) was given to the volunteers for 4 weeks. OUTCOME MEASURES: Primary outcome measures included change in creatinine-standardized, urinary F2-isoprostanes (F2-isoP) and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG). Changes in erythrocyte GSH concentrations, including total reduced glutathione (GSH), oxidized glutathione (GSSG), and their ratio (GSH:GSSG) were also measured by tandem liquid chromatography/mass spectrometry. Analysis of variance was used to evaluate differences between groups.

resultsThere were no differences in oxidative stress biomarkers between treatment groups at baseline. Thirty-nine (39) participants completed the study per protocol. Changes in creatinine standardized F2-isoP (ng/mg creatinine) (0.0±0.1 versus 0.0±0.1, p=0.38) and 8-OHdG (μg/g creatinine) (-0.2±3.3 versus 1.0±3.2, p=0.27) were nonsignificant between groups at week 4. Total reduced, oxidized, and ratio measures of GSH status were also unchanged.

conclusionsNo significant changes were observed in biomarkers of oxidative stress, including glutathione status, in this clinical trial of oral glutathione supplementation in healthy adults.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdministration, OralAdultAnalysis of VarianceAntioxidantsBiomarkersDeoxyguanosineDietary SupplementsDouble-Blind MethodErythrocytesF2-IsoprostanesFemaleGlutathioneHumansMaleMiddle Aged8-Hydroxy-2'-DeoxyguanosineAntioxidantsBiomarkersDeoxyguanosineF2-IsoprostanesGlutathione

Identifiers

PMID21875351
PMCPMC3162377
OpenAlexW2006747267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.